Synopsys Forecast, price target & analysts
Synopsys Target price 2026 - Analyst rating & recommendation
Synopsys Classifications & Recommendation
Synopsys Price Target
| Target Price | $612.00 |
| Price | $454.63 |
| Potential | 34.62% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target Synopsys 2027 . The average Synopsys target price is $612.00. This is 34.62% higher than the current stock price. The highest price target is $735.00 61.67% , the lowest is $418.92 7.86% . | |
| A rating was issued by 32 analysts: 26 Analysts recommend Synopsys to buy, 5 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Synopsys stock has an average upside potential 2027 of 34.62% . Most analysts recommend the Synopsys stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
29 Analysts have issued a sales forecast Synopsys 2026 . The average Synopsys sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
22 Analysts have issued an Synopsys EBITDA forecast 2026. The average Synopsys EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
29 Synopsys Analysts have issued a net profit forecast 2026. The average Synopsys net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current Synopsys Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Buy
➜
Buy
|
Unchanged | Oct 12 2026 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Oct 01 2026 |
| Keybanc |
Overweight
➜
Overweight
|
Unchanged | Oct 01 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 01 2026 |
| HSBC |
Hold
➜
Buy
|
Upgrade | Sep 25 2026 |
| BNP Paribas |
Underperform
➜
Neutral
|
Upgrade | Sep 24 2026 |
| Wells Fargo |
Equal-Weight
➜
Overweight
|
Upgrade | Sep 10 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Needham:
Buy
➜
Buy
|
Oct 12 2026 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Oct 01 2026 |
|
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Oct 01 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 01 2026 |
|
Upgrade
HSBC:
Hold
➜
Buy
|
Sep 25 2026 |
|
Upgrade
BNP Paribas:
Underperform
➜
Neutral
|
Sep 24 2026 |
|
Upgrade
Wells Fargo:
Equal-Weight
➜
Overweight
|
Sep 10 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
